Preview

Healthcare

Healthcare

Advanced search

Efficiency and safety of granulocyte collection for transfusion using automated peripheral blood apheresis

https://doi.org/10.65249/1027-7218-2026-8-4-11

Abstract

Objective. To determine the effectiveness and safety of collecting granulocytes by automated apheresis from healthy donors for subsequent transfusion to oncohematological patients with infectious complications associated with prolonged and profound neutropenia.
Materials and methods. 110 procedures of automated apheresis were performed on 100 volunteer donors after granulocyte mobilization using granulocyte colony-stimulating factor and dexamethasone. These procedures were conducted on MSC+ blood separators (Haemonetics, USA) (n = 56) and Spectra Optia® Apheresis System (Terumo BCT, USA) (n = 54). The effectiveness and safety of the mobilization and leukocyte apheresis procedures were evaluated, and the effectiveness of granulocyte apheresis was compared based on the type of blood separator used.
Results. The mobilization regimen used led to a 5.2-fold increase in leukocyte content in donors (from 6.4×109/l to 33.0×109/l, p < 0.001) and a 1.5-fold increase in the relative granulocyte content (from 60.4 % to 91.3 %, p < 0.001). The number of nucleated cells per blood component dose was significantly higher when using the Spectra Optia blood separator compared to the MCS+ (25.0 [16.4; 34.4]×109/dose and 14.9 [10.3; 20.0]×109/dose, respectively, p < 0.001). However, the relative granulocyte content in the final component was significantly greater when procedures were performed on the MCS+ apparatus compared to Spectra Optia (92.7 % and 84.5 %, respectively, p < 0.001). Adverse events associated with granulocyte mobilization were recorded in three cases (2.7 %), and during the apheresis procedure, in two donors (1.8 %).
Conclusion. The granulocyte mobilization regimen using granulocyte colony-stimulating factor and dexamethasone demonstrated effectiveness and safety for the donor. Granulocyte apheresis on MSC+ and Spectra Optia separators yielded a blood component with a nucleated cell content of at least 9×109 per dose and a relative granulocyte content of at least 60 %, indicating the effectiveness of granulocyte collection by these separation methods. The granulocyte apheresis procedure showed good tolerability, an absence of serious adverse effects, is safe for donors, and can be used to obtain a therapeutic (sufficient) dose of allogeneic granulocytes for the complex treatment of infectious complications in patients with neutropenia.

About the Authors

L. Huchchyna
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


A. Lipnitski
Республиканский научно-практический центр детской онкологии, гематологии и иммунологии
Belarus


W. Eremin
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


M. Potapnev
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


T. Kamenskaya
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


I. Dunayeu
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


O. Zhdanovich
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


N. Kirsanava
Республиканский научно-практический центр детской онкологии, гематологии и иммунологии
Belarus


A. Kazlouskaya
Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий
Belarus


H. Kachan
Белорусский государственный медицинский университет
Belarus


References

1. Estcourt L.J., Stanworth S., Doree C., et al. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. CDSR. 2015; 6. doi: 10.1002/14651858.CD005341.pub3.

2. West K.A., Gea-Banacloche J., Stroncek D., Kadri S.S. Granulocyte transfusions in the management of invasive fungal infections. Br J Haematol. 2017; 177(3): 357–374.

3. Fonseca S., Lampron M.-C., Pare I., et al. Production of viable and functional neutrophils in granulocyte concentrates with the Reveos automated system. Vox Sang. 2025; 120(11): 1083–1092.

4. Pawar A.A., Naqvi A.G., Verghese R., et al. A retrospective observation of donor variables and patient outcome in granulocyte harvest and its transfusion – a limited experience from a single center. Asian J Transfusion Sci. 2025. doi: 10.4103/ajts.ajts_29_25.

5. Gushchina L.M., Aleinikova O.V., Potapnev M.P., et al. Neutrophil granulocytes as a blood component for transfusion. Production technology and experience in the treatment of infectious complications of fungal etiology in children with oncohematological diseases. Hematology. Transfusiology. Eastern Europe. 2019; 5(3): 271–280. (in Russian)

6. Sever A., Rabinowicz R., Baezilai-Birenboim Sh., et al. Granulocyte transfusions in pediatric hemato-oncology: neutrophil response and CRP kinetics. Pediatr Blood Cancer. 2025; 72(11). doi: 10.1002/pbc.31979.

7. Phetsai W., Sanpakit K., Buaboonnam J., et al. Granulocyte transfusion improves survival in pediatric febrile neutropenia. Clin Exp Pediatr. 2026; 69(3): 236–246.

8. Netelenbos T., Massey E., de Wreede L.C., et al. The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions. Transfusion. 2019; 59(1): 160–168.

9. Cain L., Lafrance Ch., Morton S., et al. Differences in the product characteristics and clinical use of granulocytes for transfusion. Transfusion. 2025; 65(6): 1111–1123.

10. Nikolajeva O., Mijovic A., Hess D., et al. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation. Bone Marrow Transplant. 2015; 50(6): 846–849.

11. John L., Vaheedu A.A., Ramanadhan P., et al. Granulocyte apheresis in donors: a comparative study of spectra optia and cobe spectra apheresis systems. Transfus Apheresis Sci. 2026; 65(1). doi: 10.1016/j.transci.2025.104284.

12. Szumowski A., Wasiluk T., Sredzinska M., et al. Pooled granulocyte component – a worthy rival to the apheresis product. Adv Med Sci. 2026; 71(1): 27–39.

13. Shenoy V., Hazra A., Vaheedu A., et al. Granulocyte Concentrates derived from buffy coats versus apheresis granulocytes – differences in product characteristics and costs between two centers in India. Indian J Hematol Blood Transf. 2026; 42(3): 1018–1024.

14. Price T.H., Boeckh M., Harrison R.W., et al. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood. 2015; 126(18): 2153–2161.

15. Bashir S., Stanworth S., Massey E., et al. Neutrophil function is preserved in a pooled granulocyte component prepared from whole blood donations. Br J Haematol. 2008; 140(6): 701–711.

16. Cohen T., Simmons S.C., Pham H.P., Staley E.M. Granulocyte transfusion: clinical updates and a practical approach to transfusion. Clin Lab Med. 2021; 41(4): 647–657.

17. Heuft H.G., Goudeva L., Sel S., Blasczyk R. Equivalent mobilization and collection of granulocytes for transfusion after administration of glycosylated G-CSF (3 µg/kg) plus dexamethasone versus glycosylated G-CSF (12 µg/kg) alone. Transfusion. 2002; 42(7): 928–934.

18. Yeghen T., Devereux S. Granulocyte transfusion. Vox Sang. 2001; 81(2): 87–92.

19. Repina L.A., Potapnev M.P., Gushchina L.M. Immunophenotypic characteristics of “mobilizedˮ neutrophil granulocytes used for transfusion. Hematology. Transfusiology. Eastern Europe. 2022; 8(1): 29–40. (in Russian)

20. Cancelas J.A., Padmanabhan A., Le T., et al. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial. Transfusion. 2015; 55(4): 748–755.

21. Quillen K., Yau Y.Y., Leitman S.F. The determinants of granulocyte yield in 1198 granulocyte concentrates collected form unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience. Transfusion. 2009; 49(3): 421–426.

22. Holig K., Kramer M., Kroschinsky F., et al. Safety and efficacy of hematopoietic stem cell collection form mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009; 114(18): 3757–3763.

23. Brockmann F., Kramer M., Bornhauser M., et al. Efficacy and side effects of granulocyte collection in healthy donors. Transfus Med Hemother. 2013; 40(4): 258–264.


Review

For citations:


Huchchyna L., Lipnitski A., Eremin W., Potapnev M., Kamenskaya T., Dunayeu I., Zhdanovich O., Kirsanava N., Kazlouskaya A., Kachan H. Efficiency and safety of granulocyte collection for transfusion using automated peripheral blood apheresis. Healthcare. 2026;(8):4-11. (In Russ.) https://doi.org/10.65249/1027-7218-2026-8-4-11

Views: 147

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)